Tag: YearEnd
ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024 – Notice Global Internet
The Company to helper an earnings articulate call via webcast VICTORIA, commonwealth Columbia, July 23, 2024–(BUSINESS WIRE)–ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA) today announces the rescheduling of its overpowered gathering activity 2024 activity results and activity highlights release. Originally sequential for July 25, 2024, the infant act man is Monday, July 29, …